Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 14 Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 3 Pancreatic Neoplasms 2 Diabetes Mellitus, Type 2 2 Breast Neoplasms 2 Sleep Wake Disorders 1 Rectal Neoplasms 1 Neoplasms 1 Lymphatic Metastasis 1 Fatigue 1 Depression 1 Communicable Diseases 1

Interventions

Surveys and Questionnaires 86 Blood Specimen Collection 58 Interviews as Topic 28 Observation 15 Data Collection 15 Radiotherapy 12 Watchful Waiting 11 Magnetic Resonance Spectroscopy 11 Hematologic Tests 11 Exercise 11 Drug Therapy 11 Quality of Life 9 Biopsy 8 Specimen Handling 7 Therapeutics 6 Restraint, Physical 6 Magnetic Resonance Imaging 6 Focus Groups 6 pembrolizumab 5 Standard of Care 5 Rivaroxaban 5 Phlebotomy 5 Nivolumab 5 Lapatinib 5 Immune Checkpoint Inhibitors 5 atezolizumab 4 apixaban 4 Trastuzumab 4 Patient Reported Outcome Measures 4 Palliative Care 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neoplasms × Metformin × Clear all

NCT01195259 2013-10-28

Malignancy Meta Analysis for BRL49653

GlaxoSmithKline

Diabetes Mellitus, Type 2, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡